MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,119,394 | -10.2% | 278,223 | -25.5% | 0.14% | -11.2% |
Q2 2023 | $13,488,485 | +36.3% | 373,332 | +40.3% | 0.16% | +18.5% |
Q1 2023 | $9,893,598 | -65.7% | 266,100 | -58.2% | 0.14% | -65.0% |
Q4 2022 | $28,849,647 | +85.6% | 636,717 | +186.2% | 0.39% | +77.9% |
Q3 2022 | $15,540,000 | -21.1% | 222,508 | -24.2% | 0.22% | -28.6% |
Q2 2022 | $19,707,000 | +90.1% | 293,567 | +132.9% | 0.30% | +81.0% |
Q1 2022 | $10,364,000 | -43.4% | 126,048 | +0.9% | 0.17% | -35.9% |
Q4 2021 | $18,320,000 | -8.5% | 124,892 | +10.4% | 0.26% | -19.9% |
Q3 2021 | $20,016,000 | +31.4% | 113,143 | +20.0% | 0.33% | +15.1% |
Q2 2021 | $15,228,000 | +185.8% | 94,276 | +203.1% | 0.28% | +140.7% |
Q1 2021 | $5,328,000 | -9.8% | 31,103 | -39.9% | 0.12% | -49.6% |
Q2 2020 | $5,907,000 | -23.9% | 51,742 | -48.7% | 0.23% | -57.8% |
Q1 2020 | $7,760,000 | – | 100,953 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |